Ziekenhuis St. Jansdal
Harderwijk, Netherlands
General hospital in Harderwijk
Wethouder Jansenlaan 90, 3844 DG Harderwijk
About Ziekenhuis St. Jansdal
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
7
Radboud University Medical Center
5
Dutch Colorectal Cancer Group
3
Amgen
2
Boehringer Ingelheim
2
Borstkanker Onderzoek Groep
2
Janssen Research & Development, LLC
2
Loxo Oncology, Inc.
2
Pfizer
2
The Netherlands Cancer Institute
2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
1
Clinical Trials at Ziekenhuis St. Jansdal
During the past decade, Ziekenhuis St. Jansdal conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 7 clinical trials were completed, i.e. on
average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
1994-12-01
Completed
640
Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
1998-03-01
Completed
500
Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
1998-08-01
Completed
450
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer
2000-03-01
Completed
47
Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer
2001-02-01
2013-03-01
Completed
4,813
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
2004-03-01
Completed
Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.
2006-02-01
Completed
200
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ziekenhuis St. Jansdal" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials, followed by "Radboud University Medical Center" with 5 trials
sponsored, "Dutch Colorectal Cancer Group" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Boehringer Ingelheim"
with 2 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 27 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ziekenhuis St. Jansdal"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 3 trials as a collaborator, "Borstkanker Onderzoek Groep" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator and "ALMANAC Trialists Group" with 1 trials as a collaborator. Other collaborators include 76 different institutions and companies that were
collaborators in the rest 86 trials.
Clinical Trials Conditions at Ziekenhuis St. Jansdal
According to Clinical.Site data, the most researched conditions in "Ziekenhuis St. Jansdal" are
"Breast Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Lung Cancer" (4 trials), "Colorectal Cancer" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Ziekenhuis St. Jansdal" in a lesser frequency.
Clinical Trials Intervention Types at Ziekenhuis St. Jansdal
Most popular intervention types in "Ziekenhuis St. Jansdal" are "Drug" (32 trials), "Device" (4 trials), "Other" (4 trials), "Procedure" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Carboplatin" (4 trials), "Pemetrexed" (4 trials), "Cisplatin" (3 trials) and "cisplatin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Ziekenhuis St. Jansdal
The vast majority of trials in "Ziekenhuis St. Jansdal" are
39 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Ziekenhuis St. Jansdal
Currently, there are NaN active trials in "Ziekenhuis St. Jansdal".
1 are not yet recruiting,
9 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Ziekenhuis St. Jansdal,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Ziekenhuis St. Jansdal, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 28 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 6 trials that are defined as “Not Applicable".